We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+9.04%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$19.4B
AUM Growth
+$1.52B
Cap. Flow
+$55.8M
Cap. Flow %
0.29%
Top 10 Hldgs %
32.2%
Holding
350
New
17
Increased
136
Reduced
148
Closed
7

Top Buys

Rank Stock Value
1
PPL
PPL Corp
PPL
+$52.8M
2
OKE icon
Oneok
OKE
+$39.9M
3
MDLZ icon
Mondelez International
MDLZ
+$34.3M
4
HPQ icon
HP
HPQ
+$32.7M
5
TRV icon
Travelers Companies
TRV
+$32.4M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$52.6M
2
UPS icon
United Parcel Service
UPS
+$52.2M
3
CVX icon
Chevron
CVX
+$43.4M
4
ABT icon
Abbott
ABT
+$41.4M
5
ETN icon
Eaton
ETN
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 22.95%
2 Financials 14.09%
3 Healthcare 13.94%
4 Industrials 11.47%
5 Consumer Staples 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.82T
$1.02B 5.27%
5,936,546
-107,524
-2% -$17.2M
LLY icon
2
Eli Lilly
LLY
$1.07T
$765M 3.94%
863,598
-1,759
-0.2% -$1.58M
PG icon
3
Procter & Gamble
PG
$343B
$714M 3.68%
4,121,310
-21,913
-0.5% -$3.72M
ABBV icon
4
AbbVie
ABBV
$458B
$668M 3.44%
3,383,866
+12,304
+0.4% +$2.3M
MSFT icon
5
Microsoft
MSFT
$2.84T
$638M 3.28%
1,481,869
+46,625
+3% +$19.9M
HD icon
6
Home Depot
HD
$332B
$530M 2.73%
1,308,071
+46,640
+4% +$17M
NEE icon
7
NextEra Energy
NEE
$187B
$504M 2.59%
5,958,218
-23,542
-0.4% -$1.84M
MRK icon
8
Merck
MRK
$324B
$503M 2.59%
4,431,001
+168,688
+4% +$20M
MDLZ icon
9
Mondelez International
MDLZ
$77.7B
$459M 2.36%
6,227,505
+488,051
+9% +$34.3M
PEP icon
10
PepsiCo
PEP
$186B
$450M 2.32%
2,644,263
-610
-0% -$105K
MRSH
11
Marsh
MRSH
$86.3B
$430M 2.22%
1,928,915
+86,639
+5% +$19.2M
JPM icon
12
JPMorgan Chase
JPM
$939B
$425M 2.19%
2,015,899
+82,308
+4% +$17.3M
TXN icon
13
Texas Instruments
TXN
$255B
$378M 1.94%
1,828,182
-7,590
-0.4% -$1.53M
WMB icon
14
Williams Companies
WMB
$90.5B
$374M 1.93%
8,191,510
+527,358
+7% +$23.2M
SRE icon
15
Sempra
SRE
$60.8B
$356M 1.83%
4,254,569
-15,335
-0.4% -$1.23M
ETN icon
16
Eaton
ETN
$157B
$352M 1.81%
1,062,983
-118,571
-10% -$36.2M
CVX icon
17
Chevron
CVX
$388B
$350M 1.8%
2,376,838
-291,841
-11% -$43.4M
APD icon
18
Air Products & Chemicals
APD
$66.3B
$344M 1.77%
1,155,198
-10,368
-0.9% -$2.84M
MCD icon
19
McDonald's
MCD
$188B
$343M 1.77%
1,127,349
-4,332
-0.4% -$1.19M
PNC icon
20
PNC Financial Services
PNC
$100B
$343M 1.77%
1,855,074
-21,608
-1% -$3.79M
LMT icon
21
Lockheed Martin
LMT
$134B
$327M 1.68%
558,757
-861
-0.2% -$462K
ADP icon
22
Automatic Data Processing
ADP
$100B
$286M 1.47%
1,032,415
+59,289
+6% +$15.5M
TRV icon
23
Travelers Companies
TRV
$80.8B
$266M 1.37%
1,137,647
+146,987
+15% +$32.4M
BR icon
24
Broadridge
BR
$17.2B
$237M 1.22%
1,100,341
-8,526
-0.8% -$1.78M
PAYX icon
25
Paychex
PAYX
$40.4B
$229M 1.18%
1,704,046
+133
+0% +$16.9K

Similar funds

Bahl & Gaynor's Q3 2024 Portfolio in Review

As of Q3 2024, Bahl & Gaynor held 350 positions worth $19.4B, up 8.5% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q3 2024 filing shows 17 new, 136 increased, 148 reduced and 7 closed positions. Its largest new stake was Gildan: 253,547 shares worth $11.9M. The largest sale was Amgen, an estimated $52.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q3 2024 buy was Gildan: 253,547 shares worth $11.9M.
  • Bahl & Gaynor added most to PPL Corp in Q3 2024, an estimated $52.8M increase.
  • Bahl & Gaynor's biggest Q3 2024 reduction was Amgen, cutting an estimated $52.6M.
  • Bahl & Gaynor fully exited Stepan Co in Q3 2024, selling an estimated $1.63M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $19.4B portfolio in Q3 2024.
  • Bahl & Gaynor opened 17 new positions and closed 7 in Q3 2024.
  • Bahl & Gaynor's portfolio value rose 8.5% quarter-over-quarter to $19.4B.

Based on Bahl & Gaynor's 13F filing for Q3 2024, filed 12 Nov 2024.